Jason Grant KETTLE

Person

Macclesfield, GB

People

Patents Grantslast 30 patents

Information Patent Grant
JAK1 selective inhibitors
- Patent number 11,897,869
- Issue date Feb 13, 2024
- AstaZeneca AB
- Karl Magnus Nilsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolopyrimidine compounds and their use in treating cancer
- Patent number 11,851,432
- Issue date Dec 26, 2023
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Frederick Woolf Goldberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetracyclic heteroaryl compounds
- Patent number 11,407,765
- Issue date Aug 9, 2022
- AstraZeneca, AB
- Jason Grant Kettle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for inhibiting JAK
- Patent number 11,247,983
- Issue date Feb 15, 2022
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Annika Birgitta Margareta Astrand
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyrimidine compounds and their use in treating cancer
- Patent number 11,084,827
- Issue date Aug 10, 2021
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Frederick Woolf Goldberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phenoxyquinazoline compounds and their use in treating cancer
- Patent number 11,053,223
- Issue date Jul 6, 2021
- Astrazeneca AB
- Tudor Grecu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK1 selective inhibitors
- Patent number 10,961,228
- Issue date Mar 30, 2021
- Astrazeneca AB
- Karl Magnus Nilsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C5-anilinoquinazoline compounds and their use in treating cancer
- Patent number 10,829,479
- Issue date Nov 10, 2020
- Astrazeneca AB
- Jason Kettle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for inhibiting JAK
- Patent number 10,654,835
- Issue date May 19, 2020
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Annika Birgitta Margareta Astrand
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 10,597,405
- Issue date Mar 24, 2020
- Astrazeneca AB
- Jason Grant Kettle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and their use in treating cancer
- Patent number 10,519,152
- Issue date Dec 31, 2019
- Astrazeneca AB
- Bin Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C5-anilinoquinazoline compounds and their use in treating cancer
- Patent number 10,273,227
- Issue date Apr 30, 2019
- Astrazeneca AB
- Jason Kettle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for inhibiting JAK
- Patent number 10,167,276
- Issue date Jan 1, 2019
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Annika Astrand
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for inhibiting JAK
- Patent number 9,714,236
- Issue date Jul 25, 2017
- AstraZeneca AB
- Neil Grimster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-anilino quinazoline derivatives as antiproliferative agents
- Patent number 8,399,667
- Issue date Mar 19, 2013
- Astrazeneca AB
- Robert Hugh Bradbury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents
- Patent number 7,947,676
- Issue date May 24, 2011
- Astrazeneca AB
- Bernard Christophe Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine derivatives for inhibiting Eph receptors
- Patent number 7,718,653
- Issue date May 18, 2010
- Astrazeneca AB
- Bernard Christophe Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives
- Patent number 7,625,908
- Issue date Dec 1, 2009
- Astrazeneca AB
- Laurent Francois Andre Hennequin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives
- Patent number 7,148,230
- Issue date Dec 12, 2006
- AstraZeneca AB
- Robert Hugh Bradbury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives as MCP-1 receptor antagonists
- Patent number 6,984,657
- Issue date Jan 10, 2006
- Astrazeneca AB
- Alan Wellington Faull
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monocyte chemoattractant protein-1 inhibitor compounds
- Patent number 6,953,809
- Issue date Oct 11, 2005
- Zeneca Limited
- Alan Wellington Faull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-inflammatory indole derivatives
- Patent number 6,911,465
- Issue date Jun 28, 2005
- Astrazeneca AB
- Allan W Faull
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 6,833,387
- Issue date Dec 21, 2004
- Astrazeneca AB
- Alan W. Faull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole derivatives and their use as MCP-1 antagonist
- Patent number 6,737,435
- Issue date May 18, 2004
- Astrazeneca AB
- Jason G Kettle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives and their use as MCP-1 receptor antagonists
- Patent number 6,613,760
- Issue date Sep 2, 2003
- Astrazeneca AB
- Jason Kettle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-inflammatory indole derivatives
- Patent number 6,569,888
- Issue date May 27, 2003
- Astrazeneca AB
- Jason Kettle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic pyrrole derivatives as MCP-1 inhibitors
- Patent number 6,479,527
- Issue date Nov 12, 2002
- AstraZeneca UK Limited
- Andrew J. Barker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monocyte chemoattractant protein-1 inhibitor compounds
- Patent number 6,441,004
- Issue date Aug 27, 2002
- Zeneca Limited
- Alan Wellington Faull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chemical compounds
- Patent number 6,291,507
- Issue date Sep 18, 2001
- AstraZeneca UK Limited
- Alan W Faull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole derivatives as MCP-1 receptor antagonists
- Patent number 6,288,103
- Issue date Sep 11, 2001
- Zeneca Limited
- Alan Wellington Faull
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREA...
- Publication number 20240374606
- Publication date Nov 14, 2024
- AstraZeneca AB
- Sten NILSSON-LILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER
- Publication number 20240217980
- Publication date Jul 4, 2024
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Frederick Woolf GOLDBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK1 SELECTIVE INHIBITORS
- Publication number 20240208947
- Publication date Jun 27, 2024
- AstraZeneca AB
- Karl Magnus NILSSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND THEIR USE IN TREATING CANCER
- Publication number 20230374007
- Publication date Nov 23, 2023
- AstraZeneca AB
- Iacovos Neal Michaelides
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED TRICYCLIC COMPOUNDS USEFUL AS ANTICANCER AGENTS
- Publication number 20220204527
- Publication date Jun 30, 2022
- AstraZeneca AB
- Jason Grant KETTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS
- Publication number 20220127281
- Publication date Apr 28, 2022
- AstraZeneca AB
- Jason Grant KETTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING JAK
- Publication number 20220119372
- Publication date Apr 21, 2022
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Annika Birgitta Margareta ASTRAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER
- Publication number 20210340150
- Publication date Nov 4, 2021
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Frederick Woolf GOLDBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRACYCLIC HETEROARYL COMPOUNDS
- Publication number 20210221823
- Publication date Jul 22, 2021
- AstraZeneca AB
- Jason Grant KETTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK1 SELECTIVE INHIBITORS
- Publication number 20210188821
- Publication date Jun 24, 2021
- AstraZeneca AB
- Karl Magnus NILSSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER
- Publication number 20210087196
- Publication date Mar 25, 2021
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Frederick Woolf GOLDBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING JAK
- Publication number 20210078981
- Publication date Mar 18, 2021
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Annika Birgitta Margareta ASTRAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER
- Publication number 20200223828
- Publication date Jul 16, 2020
- AstraZeneca AB
- Tudor GRECU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS
- Publication number 20200109153
- Publication date Apr 9, 2020
- AstraZeneca AB
- Jason Grant KETTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK1 SELECTIVE INHIBITORS
- Publication number 20190367490
- Publication date Dec 5, 2019
- AstraZeneca AB
- Karl Magnus NILSSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C5-anilinoquinazoline Compounds and Their Use in Treating Cancer
- Publication number 20190263787
- Publication date Aug 29, 2019
- AstraZeneca AB
- Jason KETTLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Their Use in Treating Cancer
- Publication number 20190194190
- Publication date Jun 27, 2019
- AstraZeneca AB
- Bin YANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20190177338
- Publication date Jun 13, 2019
- AstraZeneca AB
- Jason Grant Kettle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING JAK
- Publication number 20190092760
- Publication date Mar 28, 2019
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Annika ASTRAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER
- Publication number 20180312490
- Publication date Nov 1, 2018
- AstraZeneca AB
- Jason KETTLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING JAK
- Publication number 20170320857
- Publication date Nov 9, 2017
- AstraZeneca AB
- Annika ASTRAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING JAK
- Publication number 20170088543
- Publication date Mar 30, 2017
- AstraZeneca AB
- Annika ASTRAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINE DERIVATIVES
- Publication number 20130005727
- Publication date Jan 3, 2013
- AstraZeneca AB
- Robert Hugh BRADBURY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE DERIVATIVES
- Publication number 20110046108
- Publication date Feb 24, 2011
- AstraZeneca AB
- Jason Grant Kettle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS
- Publication number 20100152442
- Publication date Jun 17, 2010
- AstraZeneca AB
- Robert Hugh Bradbury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20090203663
- Publication date Aug 13, 2009
- AstraZeneca AB
- Jean Claude Arnould
- C07 - ORGANIC CHEMISTRY
Information Patent Application
L-Phenylalanine Derivatives
- Publication number 20090137601
- Publication date May 28, 2009
- AstraZeneca AB
- Simon Thomas Barry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE DERIVATIVES 934
- Publication number 20090023719
- Publication date Jan 22, 2009
- AstraZeneca AB
- Bernard Christophe Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS
- Publication number 20080269487
- Publication date Oct 30, 2008
- AstraZeneca AB
- Robert Hugh Bradbury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PYRIMIDINE DERIVATIVES 698
- Publication number 20080242663
- Publication date Oct 2, 2008
- AstraZeneca AB
- Susan Elizabeth Ashton
- C07 - ORGANIC CHEMISTRY

Jason Grant KETTLE

Person

Patents Grantslast 30 patents

JAK1 selective inhibitors

Triazolopyrimidine compounds and their use in treating cancer

Tetracyclic heteroaryl compounds

Compounds and methods for inhibiting JAK

Triazolopyrimidine compounds and their use in treating cancer

Phenoxyquinazoline compounds and their use in treating cancer

JAK1 selective inhibitors

C5-anilinoquinazoline compounds and their use in treating cancer

Compounds and methods for inhibiting JAK

Chemical compounds

Compounds and their use in treating cancer

C5-anilinoquinazoline compounds and their use in treating cancer

Compounds and methods for inhibiting JAK

Compounds and methods for inhibiting JAK

4-anilino quinazoline derivatives as antiproliferative agents

Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents

Pyrimidine derivatives for inhibiting Eph receptors

Quinazoline derivatives

Quinazoline derivatives

Indole derivatives as MCP-1 receptor antagonists

Monocyte chemoattractant protein-1 inhibitor compounds

Anti-inflammatory indole derivatives

Chemical compounds

Indole derivatives and their use as MCP-1 antagonist

Indole derivatives and their use as MCP-1 receptor antagonists

Anti-inflammatory indole derivatives

Bicyclic pyrrole derivatives as MCP-1 inhibitors

Monocyte chemoattractant protein-1 inhibitor compounds

Chemical compounds

Indole derivatives as MCP-1 receptor antagonists

Patents Applicationslast 30 patents

SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREA...

TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER

JAK1 SELECTIVE INHIBITORS

COMPOUNDS AND THEIR USE IN TREATING CANCER

FUSED TRICYCLIC COMPOUNDS USEFUL AS ANTICANCER AGENTS

HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS

COMPOUNDS AND METHODS FOR INHIBITING JAK

TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER

TETRACYCLIC HETEROARYL COMPOUNDS

JAK1 SELECTIVE INHIBITORS

TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER

COMPOUNDS AND METHODS FOR INHIBITING JAK

PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER

HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS

JAK1 SELECTIVE INHIBITORS

C5-anilinoquinazoline Compounds and Their Use in Treating Cancer

Compounds and Their Use in Treating Cancer

CHEMICAL COMPOUNDS

COMPOUNDS AND METHODS FOR INHIBITING JAK

C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER

COMPOUNDS AND METHODS FOR INHIBITING JAK

COMPOUNDS AND METHODS FOR INHIBITING JAK

QUINAZOLINE DERIVATIVES

PYRIMIDINE DERIVATIVES

4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS

CHEMICAL COMPOUNDS

L-Phenylalanine Derivatives

PYRIMIDINE DERIVATIVES 934

4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS

NOVEL PYRIMIDINE DERIVATIVES 698